Financial Report

 
 



Dabur India Limited
ICON Press Release

Home        
Dabur India Limited
ICON Press Release
 

 

DABUR INDIA LIMITED: FINANCIAL BENCHMARKS AVAILABLE

SAN DIEGO, Calif. - – ICON Group International Ltd., today released a study global on labor productivity and financial benchmarks for Dabur India Limited (BOM).

What?

International Competitive Benchmarks and Financial Gap Analysis

How does Dabur India Limited’s balance sheet structure differ from global benchmarks? Does Dabur India Limited hold more cash and short-term assets, or does it concentrate its assets in physical plant and equipment? Does it have a higher percent of payables compared to the benchmarks? Does it hold a higher concentration of long-term debt? Does Dabur India Limited have a relatively higher cost of goods sold, operating costs, income taxes, or profit margins compared to global benchmarks?

Reports for over 127 Drugs companies are available now, including the following:

Abbott Laboratories
Allergan, Inc
ALPharma Incorporated.
Amgen Incorporated
Barr Laboratories Inc.
Bristol-Myers Squibb Co
Cambrex Corporation
Carter-Wallace, Inc.
Eisai Co., Ltd.
Forest Laboratories, Inc.
ICN Pharmaceuticals, Incorporated
Johnson & Johnson
King Pharmaceuticals Incorporated
KV Pharmaceutical Co.
Mylan Laboratories Inc.
Nature's Sunshine Products, Inc
NBTY Inc.
Nutraceutical International Corp
Perrigo Company
Schering-Plough Corporation
Sigma-Aldrich Corporation
Syncor International Corporation
Watson Pharmaceuticals Inc
Weider Nutrition International, Inc.

Why?

The methodologist for this unique study is Philip Parker, Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). According to Professor Parker, “With the globalization of markets, greater foreign competition, and the reduction of barriers to entry, it becomes all the more important to benchmark a company’s financial indicators on a worldwide basis. World stock markets have recently witnessed a return to fundamental financial analysis. ” The goal of the report is to assist consultants, financial managers, strategic planners, and corporate officers in gauging certain indicators of Dabur India Limited’s financial structure.

Professor Parker states, "We are intrigued by the wide variations in basic financial and productivity measures between Dabur India Limited and other Drugs companies. The Earnings Before Interest And Taxes (EBIT), for example, varied from -6 to 48.39. We see this type of variation in the hundreds of ratios that we estimate.”

How?: Methodology

The report uses a proprietary methodology to generate international financial benchmarks and measure gaps that might be revealed from such an exercise. Using common-size statements, ICON Group International Ltd. prepares these vertical analyses by pooling statistics on tens of thousands of companies across over 40 countries and applying a seven-stage methodology. (1) identification of industry classifications, (2) firm-level data collection and aggregation, (3) standardization of raw statistics, (4) filtering outliers, (5) calculation of global norms, (6) projection of deviations and gaps, and (7) projection of ranks and percentiles.

Previously available only through booksellers such as Hoovers, Amazon.com, and Barnes and Noble, ICON studies are now available directly from the publisher at a 50% discount off the cover price ($210). E-mail for more information.

 

FINANCIAL BENCHMARKS

Audience: designed for financial managers, directors, CFOs, strategic planners
Price: $210
Pages: 133 pp
Published:  
Table of Contents
About the Author(s)
Methodology/Excerpt (free to view)
Order Via Fax
Order Online

 

About ICON Group Ltd.

ICON Group Ltd. assists managers with global benchmarking, gap analysis, and productivity studies. Clients can create their own benchmarks by choosing their competitors from among over 20,000 companies. 

CONTACT: 

Orders & Customer Service 
ICON Group International, Inc.
7404 Trade St.
San Diego, CA 92121
USA
Fax: 858-635-9414
E-mail:  

 

Link: http://www.icongrouponline.com/PR/Dabur_India_Limited_IN/PR.html

 

  • Search:
  • Additional links you may find of interest:

Important Disclaimer: This report was not prepared on behalf of or for Dabur India Limited. Please refer to alternative information sources on Dabur India Limited for the following: company financials (quarterly reports, annual report, forecasting, analyst reports, stock filing history, investor reports and relations, SEC or EDGAR documents, 10K, 10Q, articles, news press releases, projections, predictions, forecasts), products or services (warranty, guarantee, credit, equipment, accessory or accessories, service, repair or repairs, rebates or rebate policy, product discount or discounts, part or parts supply, price or prices, book value or valuation, logo design), personnel information (jobs, careers, career training, job placement, employment, human resources department, employee compensation or salaries, salary policy, benefit policies for employees, university benefits, credit union benefits), finding corporation location or contact information (map, company mail, mailing street address, corporate investor contacts, website web site, email search, e-mail addresses, regional offices, dealers list, distributors listing, stores directory, outlets, contact names, CFO, CEO, COO, CIO, CTO, HR, office manager, people, welcome, conference, etc.), geographic or production locations (e.g. USA, UK, Canada, Europe, Asia, Africa, China), legal structure or business activity (corporation, incorporated, company, partner, partnership, partnerships, alliances, limited liability, corp., inc, ltd, co, lawsuit or lawsuits), management plans (marketing strategy or strategic intelligence). ICON reports do not comment on any of the above.